Why Amgen’s pick as Onyx’s new president sends a good signal

Ho-hum — a high-profile biotech executive exits after leading his company to a successful buyout by the industry’s largest player...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.